Toxaphene, a complex mixture of polychlorinated camphenes, was first introduced in 1945 by Hercules Co. (Wilmington, DE) as Hercules 3965. Until the mid 1980s, it was mass produced and widely used as an insecticide, particularly in the cotton-growing industry. It was also used as a piscicide to control rough fish (undesired stock) in various water systems (1) . The lipophilic, persistent, and volatile natures of toxaphene have contributed to its global dispersion throughout freshwater and marine environments. Traces of toxaphene have even been found in remote areas such as the Arctic (2) where the pesticide was never used. In addition to bioaccumulating in biota inhabiting these regions, toxaphene also has been detected in humans (3) (4) (5) (6) (7) (8) (9) (10) . Toxaphene was banned by the U.S. Environmental Protection Agency (U.S. EPA) in 1982, an example that was followed by many countries. However, in the early 1990s toxaphene detected in marine fish in Europe caused concern about the relationship of human health and fish consumption. Therefore, increased attention has been focused on toxaphene, both in the analytic and toxicologic fields. Research in this field has received further impetus with the synthesis of individual compounds of toxaphene and their increasing commercial availability (11, 12) . Using individual standards, we can gain more insight into the transport, fate, and toxicological effects of toxaphene in the environment. Although identification of individual congeners provides more detailed information, it also leads to more complicated analyses. Another problem lies in the nomenclature of individual compounds. Proposals have been published recently for codes simpler than the systematic nomenclature now in use. These proposals will be discussed in this review.
In 1997 a European research project titled "Investigation into the Monitoring, Analysis and Toxicity of Toxaphene" (MATT) was initiated. As part of the project, an update of available knowledge on the developments in toxaphene analysis, new environmental data, and toxicology was prepared. To avoid duplication of the extensive review on toxaphene published by Saleh in 1991 (1) , this review concentrates on developments since 1990.
Physical and Chemical Properties
Toxaphene (CAS No. 8001-35-2) was one of the main products produced by the Hercules Co. in the United States (1) . The process of producing toxaphene consists of extracting crude ax-pinene from pine Manuscript received at EHP30 July 1998; accepted 20 October 1998. produces camphene, bornylene, and uo-terpineol. The camphene is then subsequently chlorinated under ultraviolet (UV) light to produce toxaphene. The average chlorine content is 67 to 69% (13) . Structures of the main components of toxaphene are shown in Figure 1 .
Toxaphene is a yellow, waxy solid and has a mild terpene odor, with softening occurring at a temperature range of 343 to 363K. Although readily soluble in most organic solvents, it is more soluble in aromatic than aliphatic hydrocarbons. Its average elemental composition is C1oH1oC18 (1) . 1Toxaphene comprises at least 180 to 190 comnponents, most with the formula Cl(H18-nCln or C10H16-,Cln, where n is 6 to 10 (14). Buser et al. (15) report that polychlorobornanes (C10H18 nCL, n= [5] [6] [7] [8] [9] [10] [11] [12] are formed as the main components in a Wagner-Meerwin-type rearrangement reaction. The peak area percentage of all components identified, measured using the electron capture detector (ECD), amounts to 50% of the total toxaphene area (1) .
The commercial product is relatively stable but may be degraded by losing HCI or Cl2 with prolonged exposure to sunlight, alkali, or temperatures above 393K (16) . Saleh (1) found that technical toxaphene does not undergo a serious change wvhen exposed to normal sunlight. Saleh and Casida (17) and Parlar et al. ( 18) reported that irradiation at wavelengths below 290 nm results in reductive dechlorination and dehydrochlorination; radiation above 290 nm does not appear to affect toxaphene composition. When adsorbed on silica, however, technical toxaphene is completely mineralized to C02 and HCl at 230 nm (19) .
A specific gravity of 1.6 kg liter-1 has been reported for technical toxaphene (20) . Vapor pressure and the log octanolwater partition coefficient (Ko,,) value have been estinmated to be comparable to that of hexachlorobenzene (HCB), 1.73 x 10-3 Pa at 298K (21) , and a log KO,,, of 5.5 (22) .
Howard (23) and Sullivan and Armstrong (24) recorded KOU, values of 4.82 to 6.4, respectively. A log Kol0, value of 6.44 was recorded by Hooper et al. (25) . This is somewhat lower than that of technical polychlorinated biphenyl (PCB) mixtures but higher than those ofp,p'-DDT and its metabolites, suggesting that the bioconcentration of toxaphene is high. These data are diffictult to compare because of the variety of mixtures used. The numbering of skeletons Dand Eis as proposed by Hainzl (63 (24) .
The most important factor determining the flux between the air-water interface is the Henry's law constant (H). Murphy et al. (29) measured H for a technical mixture of toxaphene congeners as 0.62 Pa m3 mole-1 at 293K. Using fugacity-based equations (22, 30) , the direction and magnitude of the flux can be calculated according to McConnell et al. (31) , who assumed that the temperature slope determined by Tateya et al. (32) for PCBs is also valid for toxaphene. Using the H measurement, a toxaphene-specific intercept can be determined and from that a temperaturecorrected H can be obtained. This value allows the direction of the flux to be calculated. Such calculations suggest that up to 2 kg of material would be deposited in Lake Baikal, Russia, per month by gas exchange; the process is further enhanced by the low water temperatures of the lake (32) . More accurate congener-specific H values are required to improve these estimates. This flux direction of air to water has also been recorded by Bidleman et al. (33) . Hoff et al. (34) report that additional inputs via precipitation and particle deposition are likely to be 10 to 20 times less than those from gas absorption.
Most chlorinated bornanes contain at least one chlorine atom at C2 and C1O, whereas the bridging carbons, C1 and C4, are nonchlorinated (35) . Technical toxaphene, as synthesized by photoinduction, has a high percentage of com- (14, 36) demonstrated that in soil 2,2,5-endo,6-exo,8,9, 10-heptachlorobornane, 2,2,5-endo,6-exo,8,8,9, 1 0-octachlorobornane, 2,2,5-endo,6-exo,8,9,9,10-octachlorobornane, 2,2,3-exo,5-endo, 6 -exo,8,9,9, 10-nonachlorobornane, 2,2,5-endo,6-exo,8,8,9, 10,10-nonachlorobornane, and 2,2,5-endo,6-exo,8,9,9,10,10-nonachlorobornane (B[30012] -(1 11), B[30012] - (211) , B[30012] - (121) , B[32012] - (121) , B[30012] - (212) , and B[30012] - (122) [ (37) and as discussed in "Nomenclature"] were all dechlorinated by reductive removal of one chlorine atom from each geminal dichloro group beginning with that in the C2 position, which is the most labile under anaerobic conditions. The authors suggest that dechlorination also occurs during photodegradation and that the dechlorination rate is nonachlorobornanes > octachlorobornane > heptachlorobornanes. Fingerling et al. (14) also found that during irradiation in solvents, the bornane structure is generally preserved and photoability seems to depend on the presence of a geminal dichloro group in C2 position. The dechlorination rate is enhanced by an additional chlorine atom in the C3 position but not by a dichloro group in C5 position. Components with only a single chlorine atom at each secondary ring atom in alternating orientation, for example, 2-endo,3-exo,5-endo,6-exo,8,8,10,10-octachlorobornane, 2-endo,3-exo, 5-endo, 6-exo,8,8,9,10,10-nonachlorobornane, or 2-endo,3-exo,5-endo,6-exo,8,9,9, 10,10-nonachlorobornane (B[12012] - (202) , B[12012] - (212) , or B[12012] - (212) [ (37) and as discussed in "Nomenclature"], were found to be extremely photostable. Sources
The Hercules Company first introduced toxaphene as an insecticide in the late 1940s (1) . In the ensuing years toxaphene had a variety of uses until it was banned by the U.S. EPA in 1982 because it was suspected of being a human carcinogen and a persistent hazardous compound to nontarget organisms. A stipulation existed that stocks could be used through 1986, as reported by Voldner and Smith (38) and Rapaport and Eisenreich (39) . By that year usage had dropped from a reported 45x 106 kg year1 to 7.20 x 106 kg year-'.
Over 180 companies are reported to have produced toxaphene since 1947 with various product names (1) (Table 1) .
In 1989 there were 168 registered uses of toxaphene in the United States (40) and more than 277 worldwide to control 65, 534 167 major insect pests encountered in the production of agricultural commodities and crops. Its use in livestock dips as a miticide and in lakes as a piscicide to control rough fish populations has been widely reported (1) . The interpolated total global use between 1950 to 1993 was 1330 x 106 kg and from 1970 to 1993, 670 x 106 kg (41) . This estimation was based on data from the literature and on contacts with international agencies and researchers; data quality varies and shows large spatial and temporal gaps.
The United States (42) , the Central American states, and the former Soviet states have recorded the highest usage of toxaphene. This may be because more detailed information on usage was received from these countries, whereas in other countries information often is not recorded or is kept confidential (41) . El-Sebae et al. (28) report that toxaphene continues to be used in African countries, especially Ethiopia, Sudan, Tanzania, and Uganda where field runoff eventually flows into the Nile and ultimately into the Mediterranean Sea. These runoffs could be a source of future contamination. Information is lacking for other African countries.
In 1970 toxaphene was used in a formulation called polydophen, which was composed of 20% DDT and 40% toxaphene in a diesel fuel oil solvent. This was recommended as a substitute for DDT in Central Asia (31) . Bidleman et al. (43) and Voldner and Schroeder (44) 
Systematic Names
It is a complex task to formulate systematic names for all groups of compounds mentioned above ( Table 1 ) that conform to IUPAC rules. The structure of these compounds is given in Figure 1 . The generally accepted systematic nomenclature for bornanes, according to IUPAC rules, is based on the following rules and agreements ( Figure IA) (Figure 1 B) and bornadienes ( Figure 1C ) the following agreements and additonal rules should be applied: * If one double bond is present, the carbon atoms at this bond are numbered C2 and C3. * If two double bonds are present, the numbering of the six-membered ring should result in the lowest possible numbers, as with the bornanes. * As with the bornanes, the C9 carbon should be positioned over the C2-C3 double bond.
The systematic names are even more complicated for chlorinated camphenes ( Figure ID ) and dihydrocamphenes ( Figure  1E ) than for the chlorinated bornanes, bornenes, and bornadienes. Coelhan and Parlar (75) suggest that the systematic name for nonsubstituted camphene should be 2,2-dimethyl-3-methylene-8,9, 1 0-trinorbornane and that other substituted camphenes should be regarded as derivatives of 8,9,1 0-trinorbornane. However, according to Vetter (76) , IUPAC has abolished the name norbornane, which was used to indicate the bornane structure without C8, C9, and CIO. In addition, considering chlorinated camphenes and dihydrocamphenes to be chlorinated 8,9,10-trinorbornanes creates even longer systematic names. Moreover, such names would strongly depend on the substituents present.
Systematic names for chlorinated camphenes and dihydrocamphenes can also be regarded to have bicyclo(2.2.1) heptane as their basic structure (64, 75 Hainzl (63) proposed systematic names based on a fixed numbering of the camphene skeleton ( Figure 1D ,E). This approach is quite straightforward, resembles the bornane nomenclature, and is more user friendly. However, IUPAC does not yet support assigning these fixed numbers and, in addition, there still are no IUPAC rules for designating C8 and C9 orientations in camphene (76) .
Nomencature Systems
Because chlorinated bornanes are the most abundant compounds in technical toxaphene, most attention has been devoted to them, both with regard to analytic method development and monitoring, and nomenclature. In the past systematic nomenclature of the bornane skeleton has been nonuniform because several authors have cited the IUPAC nomenclature incorrectly, particularly the C8 and C9 positions ( Figure 1 ) (74) . Difficulties in formulating the correct systematic names for chlorinated bornanes were solved when IUPAC assigned definitive numbering for the carbon skeleton.
Because of the extensive systematic names for chlorinated bornanes (e.g., 2-endo,3-exo,5-endo,6-exo,8,9,9, 10, 10-nonachlorobornane), isolated congeners were often designated by simpler names such as T12, Toxicant A, Toxicant Ac, Toxicant B, TOX8, and TOX9; however, a clear nomenclature system was lacking. Several authors proposed and used more systematic nomenclatures in attempts to remedy this situation. Table 3 gives an overview of these nomenclatures, which will be discussed below.
The nomenclature used by Burhenne et al. (11) 12) will be part of the same coding system without any class distinction; c) the theoretical number of chlorinated bornanes, camphenes, and dihydrocamphenes will require many thousands of codes, which will be at least 4 digits. Presently, 17 chlorinated bornanes and 5 chlorinated camphenes have been assigned Parlar numbers (Table 3) .
A binary coding system for chlorinated bornanes was proposed by Nikiforov et al. (78) . The possible chlorination positions were ordered according to IUPAC order of preference into a 13-digit binary number. A "1 " is assigned if a chlorine is present and a "0", if not. This binary number is then converted into a short 4-digit decimal number. However, 5 of the maximum number of 18 substitution positions had to be fixed. This was determined on the basis of the assumption that environmentally important congeners have at least one chlorine at C10, not more than two chlorines at C8, C9, and C0O, and no chlorine at C4. Using this assumption, the code can be limited to 4 digits instead of 6 but cannot be used for all the theoretically possible congeners. Applying the nomenclature to 2,2,5-endo,6-exo,8,9, 10-heptachloroborane (Figure 2A ) results in the code HpCB-6452; these characters are the acronym for heptachloroborane. However, the enantiomer given in Figure 2B , which is chlorinated at positions 2-exo,3-endo, 6,6,8,9,10, (74) . Care should be taken when decoding the first part of the code: the binary 9-digit number must be read from the right to the left starting with 2-exo. This was noted incorrectly by Lau et al. (81) , who were subsequently cited in Nordic Council of Ministers (16) and Wester et al. (37 bornanes by listing them in order of preference according to IUPAC rules. The congeners were split into a series of homologs to restrict the code length to less than 5 digits, which is necessary if all possible congeners are tabulated by the method used for chlorinated biphenyls (82) . With this method the maximum number of digits is 4. The code is preceded by a character to indicate whether the compound is a bornane (B) , camphene (C), bornadiene (D), or bornene (E), and a number denoting the degree of chlorination (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . For example, the enantiomers in Figure 2 are coded B7-515 and are distinguished by "a"-or "b"-, but b-coded enantiomers correspond to incorrect structural names (71) if IUPAC rules are applied. The disadvantage of this method is that structural information can only be obtained after consulting extensive tables or by using a computer program that currently are only available for chlorinated bornanes.
Wester et al. (37) proposed a nomenclature system that is a mixture of the systems previously mentioned, with advantages that the structural information can be directly deduced and that the nomenclature is applicable to chlorinated bornanes as well as to chlorinated bornenes and bornadienes. The proposed system yields a code consisting of two parts. The digits in the first part of the code reflect the degree of chlorination of carbons C2 to C6, presented according to the rules listed in Table 4 . C4, i.e., the third digit, can only have a code of 0 or 1. The digits in the second part indicate the number of chlorine atoms of C8 to CIO. Wester et al. (37) extended their nomenclature to indude bornenes and bornadienes, which is easily done because of structural similarity. Only one chlorine atom can be attached to a carbon atom participating in a double bond. Only a "0" or "1" can be assigned to such a carbon. For example, 2,5-endo,6-exo,8,9,9,10,10-octachloroborn-2-ene will be coded E[10012]- (122) Polychlorinated camphene and dihydrocamphene structures could not be represented by codes based on the system previously described because of the large differences among structures. However, Wester et al. (80) developed a coding system analog to their system for bornanes, bornenes, and bornadienes (37) . The 122 numbering of the carbon atoms in the skeleton is the same as that proposed by Hainzl (83) ; however, the "a" and "b" indications of the substituents at CI0 (63) have been replaced by "'E" (trans) and "Z" (cis), respectively ( Figure 2A ). As seen in Figure 1 , this method bears a strong resemblance to the clockwise numbering of the bornane carbon skeleton (37) . Figure 1D Table 2 .
For carbon C7, the positions of the substituents must be defined. A "0" is assigned for no substitution, "1" for substitution in the "a" position, "2" for substitution in the "b" position, and "3" for two substituents. For ClO the known "E"(trans) nomenclature corresponds with code 1 and "Z" (cis) with code 2. Carbons C8 and C9 are dealt with in the second part of the proposed code, which merely reflects the number of chlorine substituents at C8 and C9. Finally, the code is preceded with a "C" for camphenes (74) , with enantiomers being distinguished by an "r" or "s"according to Wester (37 Table 2 were applied. However, if C6 is not chlorinated, the position of its hydrogen atom is unclear, in which case a subscript selected according to the rules of Table 2 is used to denote the endo or exo position of the hydrogen atom. The second part of the code deals with C8 to Cl0, with the code reflecting the number of chlorine substituents. Finally, the code is preceded by DC (dihydrocamphenes) and enantiomers are distinguished by adding an "r" or "s" according to Wester (37 Because of this the trend at present is toward using congener-specific approaches, which is possible after the first isolation and synthesis of individual compounds (87, 88 (48, 90, 94) and silica gel (7, 89, 95) Alder and Vieth (92) . They eluted the silica column before the hexane/toluene fraction with 8 (202) were also found in that fraction. Krock et al. (96) improved on this method by using 8.0 g activated silica. The sample was eluted with 48 ml hexane to remove PCBs. This was followed by elution with 50 ml hexane/ toluene (65:35, v/v) in which the toxaphene compounds were recovered. Injection Alder et al. (100) reported that injector temperature should not exceed 513K because severe decomposition of compounds may take place. Bartha et al. (101) recommend an injector temperature below 523K. Care should be taken with active sites in the liner and the injector. It is recommended that the optimal temperature be verified by a series of simple tests, as there is much variation in injector geometry. Alawi et al. (102) showed that response factors obtained using splitless injection are lower than those obtained using on-column injection. Bartha et al. (101) reported that using pressure pulse injection (PPI) at 498K resulted in response factors 4 times that of those obtained with splitless injection. This was especially significant for compounds with a low vapor pressure and long retention times [e.g., B[30030] - (122)] (101) . With this technique, the time the compounds spend in the injector is short, so there is less chance of degradation. (108) . If the speed of the secondary separation is high enough to separate a cut from the first dimension while the next cut is being collected, it will then be possible to record a connecting set of secondary chromatograms. The complete two-dimensional chromatogram can be constructed from the secondary chromatograms, similar to that in thin-layer chromatography. A method with this capability is called comprehensive (110) . A comprehensive separation uses the whole two-dimensional separation space to generate resolution provided that the individual separations are based on different interactions (i.e., are not correlated). For a method to be comprehensive, it is necessary that the first dimension be sampled at least every peak width by the second separation dimension. The first dimension can then be constructed from the secondary chromatograms (111, 112 produce this fragment in the MS/MS mode. Therefore, it would appear that the ion at m/z = 89 (dechlorinated monochlorotropylium ion), which orginates from the m/z= 125 ion, would be more useful for quantification of toxaphene congeners (117) . However, coelution of compounds that produce this ion cannot be observed. Furthermore, the response factors with this method vary considerably for individual cogeners [B[12012] - (202) (46) , especially when the degree of chlorination was higher. In contrast, Xu et al. (119) found that GC-ECD gave results identical to those for GC-NCI/MS for quantification of individual chlorobornanes in fish samples. A possible explanation for these, which at first are contradictory observations, could be different standards used in combination with the detector, which could influence the result to a large extent, as shown by Carlin and Hoffman (86) . For example, it is possible to obtain the same results for GC-ECD and GC-NCI/MS with one standard, but largely differing results with another. Another explanation can be differences between the MS configuration used in the studies.
Gas Chromatographic Separation
ECD determination of total toxaphene is subject to insufficient selectivity, whereas NCI/MS is subject to variable response factors. Using indicator compounds as a basis for calculation of total concentration was suggested as a way to obtain precise and comparable data (92) . However, this approach can only be used successfully when the indicator compounds do not coelute with other compounds. Coelution of suggested indicator compounds was shown by heart-cut multidimensional gas chromatography (69 
Enantiomers
Usually enantiomer ratios (ERs) are used to express the ratio in which the enantiomers are present. The peak area/height of the (+)-enantiomer is divided by that of the (-)-enantiomer (120) (121) (122) (123) . When the conformation of the enantiomers eluting from a chromatographic system is not known, as with enantiomers present in toxaphene, the ER is often expressed as the peak area/height of the first eluting enantiomer divided by that of the second (124) . Using the quotient of the two enantiomers gives an undefined result when the second enantiomer is not detected. de Geus et al. (125) observed this and therefore divided the second enantiomer by the first. Of course, this approach only shifts the problem. It would be better to divide by the detection limit (which does not equal zero) when a compound is not found, but this can lead to very high or low numbers. In addition, because of the reciprocal-like scale, ERs larger than unity appear to deviate more than ERs smaller than unity (e.g., 6.7 and 5.0 vs 0.15 and 0.20). To avoid these disadvantages, the (+)-enantiomer or the first eluting enantiomer can be expressed as a proportion of the sum of the two (126 (127, 128) successfully used such an approach to study the a-chiral biotransformation of toxaphene congeners by microsomes from harbor seal, whitebeaked dolphin, sperm whale, and laysan albatross.
Separation should be enantioselective as well as isomer specific to determine EFs. Unfortunately, this doubles the number of peaks to be separated (125) . A tert-butyldimethylsilylated P-cyclodextrin phase, introduced by Blum and Aichholz (129) , has been shown to give a good enantiomer separation of toxaphene compounds (15, 104, 124, 125, 130 (104) showed that a temperature ramp of 1K resulted in much better separations compared to one of 10K. This was also found by de Geus et al. (125) . Unfortunately, slow temperature programs lead to very long run times, which can be a problem when compounds with low concentrations must be detected.
Most attention has been devoted to measuring the EFs of B[12012] - (202) (130) and de Geus et al. (125) show that other compounds can be much more interesting 'Enantiomer fraction is the abundance of the first eluting enantiomer relative to the abundance of the sum of both enantiomers (126) . hData from Kallenborn et al. (124) . cData from Alder et al. (136) . didentical extract determined with GC-ECD.
because they show more enantioselective activity (Table 7) . Parlar et al. (139) report that all parent compounds in toxaphene occur as racemates. Buser and Muller (140) 1994-1995 1985-1986 1985-1986 1985-1986 1985-1986 1985-1986 1985-1986 1985-1986 1985-1986 1990-1992 1990 (146) . Musial and Uthe (84) found that levels of CHBs in Arctic cod liver were about 2-fold lower than those in Atlantic cod (Gadus morhua). Bidleman et al. (2) reported levels of toxaphene to be equivalent to those of PCBs in zooplankton and in amphipodes collected from an ice island in the Arctic Ocean. Other organochlorines had lower concentrations. Toxaphene was found to be a major contaminant in Atlantic cod liver and herring (Clupea harengus) muscle from eastern Canadian waters, with levels similar (lipid weight basis) to those for PCB but generally higher than those for DDT (84 (94) and was composed of two major components, an octachloroborane and a nonachlorobornane. The pattern of organochlorines in tissue suggests that narwals are exposed proportionally to more volatile compounds and may be less able to metabolize some of these compounds than odontocetes living closer to sources of these contaminants.
Toxaphene was measured in landlocked Arctic char and ringed seal (Phoca hispida) from Greenland (145) . Char from the east coast of Greenland had toxaphene levels that were significantly higher than those in char from areas of the west coast. However, overall levels of toxaphene in muscle were low. Seals displayed no significant geographic variation in toxaphene levels, presumably because of their relatively high biotransformation capacity for toxaphene (128 (166) , who compared toxaphene levels in salmon from the Arctic and the Baltic and found no significant difference. Similarly, levels of toxaphene in cod liver did not differ. Toxaphene has not been used as a pesticide in Scandinavia. Andersson and Wartanian (72) analyzed toxaphene in blubber samples from various seal species collected from the Baltic and the west coast of Sweden. Toxaphene levels in Baltic seals were higher than those in animals from the west coast of Sweden. Comparison of the data for adult and juvenile seals revealed, in addition, to agerelated variation in contamination, i.e., toxaphene levels in adult Baltic ringed seals were significantly higher than those in adult grey seals from the same region and 5 to 10 times than those in juvenile ringed seals from the same region. Andersson et al. (148) reported no geographic differences in concentrations of toxaphene from animals in the Arctic region with those in corresponding species in the Baltic.
Several reports on levels of toxaphene in fish and fish products from Europe show the ubiquitous presence of toxaphene in all 132 types of fish (89, 167, 168 both fresh water and marine biota all over the world. Also, at remote areas long distances from toxaphene sources, the levels in biota can be quite high. These findings illustrate the importance of long-range transport, perhaps through the atmosphere, in the global spreading of this group of contaminants.
Toxicology
Since the late 1940s, reports have been published addressing the toxicity of the chlorinated camphenes to fish, bi mammals (172) (173) (174) (175) (176) . In ac toxaphene was found to elicit m and carcinogenic properties in ma test systems, thereby posing a t humans (25, 177) .
Toxicokindtcs and Biotansfori
The use of toxaphene as a pisci discontinued after the discovo toxaphene was persistent in the environment and its presence pi successful restocking of treated lakes with desirable fish (178, 179) . However, experiReference mental information is scarce on the depuration of toxaphene in fish and their (165) residue kinetics. Delorme et al. (180) stud-(100) ied the elimination rate of toxaphene and two of the more persistent congeners, (102) B[12012]- (202) and B[12012] - (212), in lake trout and white suckers in a natural ecosystem following intraperitoneal injection of technical toxaphene (7 pg g-' for (169) white suckers; 3.5 and 7 pg g-1 for lake (119) trout). The estimated half-lives for total toxaphene were 524 days for white suckers and 232 (high dose) and 322 (low dose) days for lake trout. Half-lives for the two (100) congeners in trout were 294 and 376 days (high dose) and 316 and 367 days (low dose), respectively. In white suckers, only (169) was injected intravenously into normo- (100) and hypolipidemic mice. In normolipidemic mice, most of the radioactivity initially was found in the liver and adrenals either in the absence or presence of LDL or (102) HDL. Four hours after application, the (100) radioactivity was redistributed into the adipose tissue. Notably, lower amounts of radioactivity were found 20 min after mice were injected with toxaphene in combination with HDL than in mice injected with 14C-toxaphene-LDL, suggesting a more efficient metabolism and disposal of toxaphene when HDL was used as a carrier.
Mohammed and co-workers initially found irds, and less 14C-radiolabeled toxaphene in the liver Idition, and adrenals and more in the kidney and utagenic heart of hypolipidemic mice (181 (184) showed that in addition to inducing cytochrome P450 and aniline hydroxylase activity in the liver, toxaphene also induces activity of these enzymes in the kidney. (1) . Keller (185) (195) conducted between 1950 and 1980. As reviewed by Saleh (1), the acute LD50 of toxaphene to laboratory mammals ranged from 5 to 1075 mg kg-', depending on the species studied and the route of exposure. In addition, female rats appeared to be somewhat more sensitive to toxaphene exposure than male rats. Among the most prominent symptoms observed in laboratory animals acutely intoxicated by toxaphene are generalized epilepticlike convulsions starting with excessive saliva production followed by vomiting and muscle spasms. In time, the frequency of convulsions increased. Finally, animals became exhausted and died from respiratory failure (173) . Pathologic changes upon toxaphene exposure may include degeneration of the brain, spinal cord, and pulmonary edema (1). Combination Toxicity. Because toxaphene was widely used as a pesticide, in addition to other pesticides, the toxicity of toxaphene alone as well as in combination with other widely used pesticides was evaluated in ICR mice after 14 days of oral administration or 90 days in drinking water (195, 196) . Overall, decreases in body weight as well as increases in liver to body weight ratios were observed in mice exposed to toxaphene and toxaphene-containing mixtures. Visually, no pathologic changes were observed in tissues from treated animals. However, proliferation along with dilatation and fragmentation of the endoplasmatic reticulum and scattering of ribosomes in the liver were pronounced. Cotreatment of mice with toxaphene and parathion resulted in higher levels of inhibition of serum cholinesterase (serum ChE) activity than did treatment of mice with toxaphene alone for up to 3 days after initial exposure. In contrast, an increase of serum ChE activity was observed in mice cotreated with toxaphene and 2,4-dichlorophenoxyacetic acid (2,4-D) compared to mice treated with toxaphene alone. Phenobarbital-induced sleeping time was reduced in mice exposed to toxaphene and toxaphene-containing mixtures, whereas no reduction was observed in mice exposed to either parathion or 2,4-D This was probably because exposure to toxaphene-containing mixtures induces the hepatic mixed-function oxygenase (MFO) system. It cannot be determined from these studies whether the combination of toxicity of toxaphene and other pesticides is synergistic or antagonistic in nature or the result of effects manifested by their components individually.
Neurotoxicity. Neurotoxic effects of toxaphene exposure such as effects on behavior and learning have been reported to occur (1) . The mechanisms underlying neurotoxicity, however, are little understood. In guinea pig, Chandra and Durairaj (194) observed histological changes in the guinea pig brain, e.g., hypoxic (disorganization) and anoxic (enlargement) changes in the neurones, upon exposure to toxaphene. Depletion of cytoplasmic organelles in the oligodendritic cells of the cerebrum was observed in guinea pigs exposed to 2 mg kg-1 toxaphene, whereas disfigurement of myelin in the brain occurred when they were exposed to the high 5 mg kg-' day-' dose. In a subsequent study, Chandra and Durairaj (197) investigated the impact of acute and subacute toxicity of toxaphene on the lipid profile in brain, liver, and kidney of guinea pig. An increase in neutral lipids and cholesterol and a reduction of phospholipids was observed in the brain. The individual phosphoglycerides phosphatidylinositol, sphingomyelin, and phosphatidic acid increased in both the acute and subacutely intoxicated guinea pig brain. On the basis of their studies, Chandra and Durairaj (197) postulated that the observed effects of toxaphene on lipid contents in brain, liver, and kidney led to membrane damage. In addition, alterations in phospholipids and cholestrol content were thought to be an adaptive mechanism to cope with the stress due to toxaphene intoxication. Furthermore, they argued that the increase of sphingomyelin in the brain might be related to neurotoxic symptoms, as an increase in sphingomyelin inhibits the permeability of the membrane to small molecules and ions.
Chandra and Durairaj (184) also observed reduced ATPase and acetylcholinesterase (AChE) activities in the brain on acute and subacute exposure of guinea pigs to similar concentrations of toxaphene. Addressing the mode of action of the neurotoxic effects of toxaphene, Chandra and Durairaj discussed that inhibition of AChE can result in neural and neuromuscular disorders. In addition, respiratory failure, which leads to hypoxic and anoxic changes, would eventually result in decreased phosphorylation and ATP production, as evidenced by inhibition of ATPases. Toxaphene in vitro inhibits brain and kidney ATPases in mammals, as well as in fish, and insects (1) . In contrast to the observed effects on brain AChE activity in the guinea pig, little effects on brain ChE activity were observed in mice treated with toxaphene and toxaphene-containing mixtures (195) . The exposure of mice to toxaphene or a toxaphene-containing mixture did not result in pathologic changes in brain and liver at the light microscopic level. Table  11 gives an overview of neurologic, reproductive, and endocrine effects caused by exposure to toxaphene.
Nephrotoxicity. The effects of toxaphene exposure on the kidney of mammals were observed in a number of studies. In the 1992 study by Chandra and Durairaj (194) , a single administration of 300 mg toxaphene kg`bw to guinea pigs resulted in no observable changes in the ultrastructure of the kidney 72 hr after exposure. In a subacute exposure study, 2 or 6 mg toxaphene kg-l day-l administered for 60 days led to vacuolization in cells of the collecting system and glomerulus, degeneration of corticol tubular cells, vacuolization, and an increase in the number of mitochondria of tubular epithelial. From this study, the authors evaluated the toxaphene-induced nephrotic changes as an adaptive mechanism in the guinea pig to cope with a disturbance in membrane-associated glycoproteins and glycolipid metabolism in liver and kidney. In a study on the impact of acute and subacute effects of toxaphene on the lipid profile in kidney, Chandra and Durairaj (197) observed an increase in phosphatidylcholine, phosphatidylinositol, and phosphatidic acid levels accompanied by a decrease in cardiolipin and sphingomyelin contents. However, no alterations in other phosphoglyceride contents were found. Both acute and subacute exposure of the guinea pig to toxaphene resulted in reduced ATPase and AChE activities in the kidney (184) . This study also indicated that toxaphene may be metabolized in the kidney in addition to the liver, as an enhanced cytochrome P450 content and induced aniline hydroxylase activity were found in the kidney when exposed to toxaphene.
Hepatotoxicity. Several studies have shown that toxaphene or toxaphenecontaining mixtures induce a number of hepatic biotransformation enzymes. Toxaphene and combinations of toxaphene with parathion (5 mg kg-') and/or 2,4-D (50 mg kg-l) induced hepatic enzymes such as cytochrome P450, benzo[a]pyrene hydroxylase, and aliesterase in mice after 7 days of oral exposure. Furthermore, the in vitro biotransformation of parathion and paraoxon was effectively enhanced using hepatic 9000 g supernatant from mice exposed to toxaphene (202) . Toxaphene and toxaphene-containing mixtures also decrease the phenobarbital-induced sleeping time in mice, suggesting an effect of toxaphene on CYP2B-type metabolizing enzymes (195) . These studies show that the toxaphene-induced increase of appropriate biotransformation enzymes, including cytochrome P450, potentially stimulates the metabolism of a number of other xenobiotics and consequently may even reduce their toxicity.
A single dose of 300 mg toxaphene kg-' bw in guinea pig did not result in histopathologic or ultrastructural changes of the liver, whereas administration of 2 or 5 mg kg-l day-l for 60 days led to a relative increase in liver weight, chronic venous congestion, mononuclear infiltration, and fatty changes in hepatocytes (194) . The effect of subacute toxicity of 2 and 5 mg toxaphene kg`day-l on the hepatic lipid profile was a decrease of phospholipids without significant alterations in glycolipid, neutral lipids, and cholestrol levels (197 (213) .
In contrast to the antiestrogenic potencies, weakly estrogenic potencies of toxaphene were observed in a number of other in vitro test systems. In the human E-screen test, 10 pm of toxaphene was shown to be weakly estrogenic (0.0001, as potent as estradiol). Interestingly, a morethan-additive estrogenic response was observed in the human E-screen test after administration of a mixture of 10 estrogenic chemicals including toxaphene (214, 215 
CarcinogeWncty
In the past, much effort has been expended on studying the carcinogenic properties of toxaphene. Table 12 gives an overview of carcinogenic and mutagenic data of toxaphene presented in the literature. Toxaphene was found to be highly carcinogenic in rat and mice and induced malignant liver tumors, reticulum cell sarcomas, sarcomas in the uterus, neoplasms in the reproductive system and/or mammary gland, and neoplasms in the pituitary, adrenal, and thyroid glands (1, 177) . The National Cancer Institute conducted a study in which neoplasms were found in the thyroid gland of the rat (218 In an attempt to further elucidate the mechanism of toxaphene-induced hepatocarcinogenicity, Hedli et al. (223) investigated two potential mechanisms: peroxisomal proliferation, which has been invoked as a nongenotoxic mechanism of hepatocarcinogenicity, and DNA adduct formation. After oral treatment of CD/1 mice for 7 days with toxaphene (0-100 mg kg-1 day-1), no increases in immunodetectable levels of CYP4A1 were detected, suggesting that peroxisomal proliferation is not involved in the toxicity of toxaphene. Furthermore, no evidence was found for DNA adduct formation in the liver of toxaphene-treated mice. On the basis of this study, the authors suggest that the hepatocarcinogenic properties of toxaphene may be exerted through a nongenotoxic or promotional mechanism rather than through a genetic mechanism.
Although in vivo no evidence for a genetic mechanism for toxaphene-induced tumor formation was found, in vitro studies showed that toxaphene is genotoxic in mammalian cell systems and mutagenic in the Ames Salmonella test without requiring metabolic activation by liver homogenates (1 (1 1 1) , for mutagenic activity in Salmonella typhimurium strains TA98 and TA100 using a validated microsuspension procedure instead of the usual plateincorporated procedure. Toxaphene was mutagenic only in the TA100 strain at concentrations of 2,500, 5,000, and 10,000 pg m1-1. In contrast, toxaphene was also mutagenic to strain TA98 at a concentration of 10,000 pg plate-1 when using the plateincorporated assay. Using the microsuspension method, none of the four tested toxaphene congeners showed mutagenic activity in strain TA100 at any of the concentrations tested (maximum concentration: 10,000 pg ml-1). A dose-dependent (10-10,000 kg plate-') increase in His revertants was also observed in strains TA97, TA98, TA100, TA102, and TA104 by Schrader et al. (225) Knowing that cell-cycle delay may interfere with the expression of genotoxicity, Steinel et al. (220) studied the effect of cell-cycle delay on the induction of SCE by toxaphene in Chinese hamster lung (Don) cells. They found that toxaphene exhibited a dose-and time-dependent decrease in cell-cycle progression. At similar concentrations of toxaphene, higher numbers of SCEs were observed and dose and treatment time relationships were demonstrated. Hence, SCE induced by toxaphene was not masked by mitotic delay and longer toxaphene treatment times were not necessary in Don Chinese hamster cells. Nevertheless, the authors support recommendations for prolonged incubation times in SCE assays affected by mitotic delay.
To study a promotional mechanism rather than a genetic mechanism for toxaphene-induced tumor formation, Kang et al. (221) Toxaphene, a Human Risk Factor
As mentioned previously, toxaphene is carcinogenic in rats and mice and also has been proven to be mutagenic (1, 178 (122) , was developed in Germany (11, 92) . The method was applied in routine analyses of many German laboratories and validated by an interlaboratory exercise (99, 235) . First reports indicated that relatively high concentrations of these toxaphene congeners were in some fish from the North Atlantic, an area from which much of Germany's fish stock is derived (100) . It was obvious that some edible fish would exceed this low MRL. Therefore, the new regulation for fish, fish products, and mussels was suspended until the end of 1996 (234, 236) to give legislators time to determine the level at which the MRL should be established to take into account the questions of, on the one hand, an acceptable level of consumer protection and, on the other hand, the necessary supply of fish and fish products. In the interim, data about the contamination of all edible fish by the three indicator congeners were collected and evaluated in order to calculate the average toxaphene intake through consumption of fish (0.22 jg person-1 day'1) (237) . At present there is no acceptable daily intake (ADI) value for toxaphene for use in conducting a risk assessment study. Therefore, the average toxaphene intake was compared with the lowest no-observed adverse effect level (NOAEL) considering a sufficient high safety factor (-25,000-50,000). In 1997 a new concept was incorporated into the German MRL for toxaphene in food of animal origin. The MRL for fish and fish products was set at 0.1 mg kg4l ww on the basis of the sum of the three indicator congeners (238) ; the MRL for all other food of animal origin was set at 0.1 mg kg-l on the basis of total toxaphene. 
